Abstract：【Objective】 To explore the intervention effect of whole-course pharmaceutical care based on Information-Motivation-Behavioral (IMB) model on elderly patients with type 2 diabetes mellitus in the community. 【Methods】 A total of 104 elderly patients with type 2 diabetes mellitus managed by Huamu Community Health Service Center in Pudong New Area of Shanghai from January 2023 to December 2024 were selected and divided into control group and observation group by random number table method, with 52 cases in each group. The control group received routine community pharmaceutical management intervention, while the observation group received whole-course pharmaceutical care intervention based on the IMB model. The blood glucose levels [Fasting Plasma Glucose (FPG), 2-hour Postprandial Plasma Glucose (2hPPG), Glycated Hemoglobin (HbA1c)], medication adherence [Morisky Medication Adherence Scale-8 (MMAS-8) score], incidence of adverse reactions, self-management ability [Summary of Diabetes Self-Care Activities (SDSCA) score] and quality of life [The 36-Item Short Form Health Survey (SF-36) score] were compared between the two groups. 【Results】 After intervention, the levels of FPG, 2hPPG and HbA1c in the observation group were lower than those in the control group (P<0.05); the MMAS-8 score, each dimension score of SDSCA and SF-36 in the observation group were higher than those in the control group; the total incidence of adverse reactions was lower than that in the control group, and all differences were statistically significant (P<0.05). 【Conclusion】 Whole-course pharmaceutical care based on the IMB model can effectively control blood glucose levels, improve medication adherence and self-management ability, optimize quality of life, and reduce the incidence of adverse reactions in elderly community patients with type 2 diabetes mellitus.
张蓓, 张莹, 许珂, 王伟. 基于IMB模型的全程药学服务对社区老年2型糖尿病患者的干预效果*[J]. 医学临床研究, 2026, 43(5): 742-745.
ZHANG Bei, ZHANG Ying, XU Ke, WANG Wei. Intervention Effect of Whole-course Pharmaceutical Care Based on IMB Model on Elderly Patients with Type 2 Diabetes Mellitus in Community. JOURNAL OF CLINICAL RESEARCH, 2026, 43(5): 742-745.
2026, Vol. 43 
